Illness	Number of cases
Heart failure (I50.01)	221
Chronic ischaemic heart disease (I25.13)	147
Atrial fibrillation and flutter - Paroxysmal atrial fibrillation (I48.0)	143
Syncope and collapse (R55)	114
Left ventricular failure unspecified (I50.13)	100
Unstable angina (I20.0)	97
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	90
Acute myocardial infarction - Non-ST elevation NSTEMI myocardial infarction (I21.4)	81
Left ventricular failure unspecified (I50.14)	78
Essential primary hypertension (I10.01)	70

Top 10 treatments

Treatment	Number
Radio-controlled cardiological telemetry (8-933)	1.281
Other investigations of the heart or blood vessels by means of a tube (catheter) (1-279.0)	683
Computed tomography of the chest with contrast medium (3-222)	551
Examination of the left side of the heart with a tube (catheter) inserted into the heart via an artery (1-275.2)	504
Additional information on materials used (8-83b.0b)	477
(9-984.7)	452
Treatment of the heart and/or the coronary arteries with access through a tube (catheter) along the blood vessels (8-837.00)	398
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	371
(9-984.8)	348
Examination of the left side of the heart with a tube (catheter) inserted via an artery and across the septum of the heart (1-274.0)	332

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ28

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
46	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
40	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
40	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies
Editors of scientific journals/textbooks
Doctoral supervision